6/26/2025

Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.

Source: Yahoo

6/26/2025

The global retinitis pigmentosa market, valued at $11.31 billion in 2024, is expected to grow to $25.87 billion by 2034, driven by gene therapy advancements, aging populations, and strategic industry collaborations. North America leads, while Asia-Pacific demonstrates rapid growth. Key players include Johnson & Johnson and Novartis AG. Retinitis Pigmentosa Market Retinitis Pigmentosa Market Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Market Opportunities and Strategies to

Source: Yahoo

6/26/2025

J&J is offering up to $100,000 in grant funding, mentorship and access to computing capabilities.

Source: Yahoo

6/26/2025

How Earle Dickson Healed Wound Care With The Band-Aid

Source: DowJones

6/25/2025

Johnson & Johnson (NYSE:JNJ) ranks among the top stocks for an early retirement portfolio. On June 13, Johnson & Johnson (NYSE:JNJ) announced that patients with relapsed or refractory large B-cell lymphoma (LBCL) showed strong response rates to its investigational dual-targeting CAR T-cell treatment. According to results given at the 2025 European Hematology Association Congress, the […]

Source: Yahoo

6/25/2025

This blend of stocks may be the key to long-term success.

Source: Yahoo

6/25/2025

Source: SeekingAlpha

6/25/2025

Johnson & Johnson (NYSE:JNJ) is one of the 10 Best and Cheap Stocks to Buy Now. On June 19, Johnson & Johnson (NYSE:JNJ) announced the launch of two new plating systems in the United States under its VOLT platform, called Distal Radius and Proximal Humerus 3.5 Plating Systems. The systems are designed to treat the two […]

Source: Yahoo

6/25/2025

Explore May 2025 market volatility, U.S.-China trade talks, and record dividend income growth.

Source: SeekingAlpha

6/25/2025

Johnson & Johnson (NYSE:JNJ) is one of the best Fortune 500 stocks to buy according to billionaires. On June 19, Johnson & Johnson (J&J) MedTech introduced two new plating systems for distal radius (wrist) and proximal humerus (upper arm near the shoulder) fractures for its Variable Angle Optimised Locking Technology /VOLT platform in the US. […]

Source: Yahoo

6/24/2025

Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, Dean Omar Branham Shirley, LLP, a Dallas, Texas-based law firm, announced an $8 million verdict against Johnson & Johnson in Suffolk County, Massachusetts. The verdict was awarded to Janice Paluzzi, an 84-year-old Massachusetts woman […]

Source: Yahoo

6/24/2025

Merck's Winrevair meets goal in a phase III study in newly diagnosed PAH patients, showing strong efficacy.

Source: Yahoo

6/24/2025

PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of resilience.

Source: Yahoo

6/24/2025

Boring dividend stocks are becoming the smartest way to profit from AI's efficiency revolution. Microsoft (NASDAQ: MSFT) is using AI-powered code-completion tools to help developers write code 55% faster. Johnson & Johnson (NYSE: JNJ) is leveraging AI to accelerate drug-discovery timelines.

Source: Yahoo

6/24/2025

Johnson & Johnson offers stability with 62 years of dividend growth and a 3.44% yield. Click for why JNJ is undervalued and poised for potential 65% upside.

Source: SeekingAlpha

6/24/2025

HEBRON, Ky. - ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, announced today that Gary Rosenblum has been named President and Chief...

Source: Finnhub

6/24/2025

Source: SeekingAlpha

6/24/2025

The product claims to offer stable and clear vision across all distances and lighting conditions.

Source: Yahoo

6/24/2025

Source: SeekingAlpha

6/24/2025

Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are undervalued vs. historical norms.

Source: SeekingAlpha